Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
JAPAN / Science & Health
Nov 24, 2022
Shionogi applies for COVID-19 vaccine approval, would be first Japan-made
The recombinant protein-based preventive vaccine is the same type as a COVID-19 vaccine developed by Novavax and differs from messenger RNA vaccines developed by Pfizer or Moderna.
Japan Times
JAPAN / Science & Health
Nov 15, 2022
Japan's Daiichi Sankyo says mRNA COVID vaccine successful in booster trial
Approval would give Japan a home-grown source for mRNA vaccines, which have made up the bulk of its COVID-19 inoculations to date.
Japan Times
BUSINESS / Companies
Oct 26, 2022
Lotte made its name in candy. Now it’s moving into drugmaking.
The new direction comes after a number of prominent South Korean family-run businesses turned to the highly profitable $1.3 trillion global biopharma business.
Japan Times
WORLD
Oct 26, 2022
New COVID boosters aren’t better than old ones, small study finds
The early results don't mean that getting a bivalent shot has no benefit, but they do raise the question of whether the switch to a new version of the vaccine was necessary.
Japan Times
WORLD / Science & Health
Oct 18, 2022
High hopes for nasal COVID-19 vaccines despite 'disappointing' trial
By entering the body the same way as the virus, nasal vaccines aim to build immunity in the mucous membrane that line the nose and mouth.
Japan Times
COMMENTARY / World
Oct 4, 2022
New Alzheimer's drug from Biogen and Eisai is just the beginning
A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.
Japan Times
JAPAN
Oct 3, 2022
Japan selects 17 projects to support vaccine manufacturing
The move came after the coronavirus pandemic highlighted issues affecting vaccine development and production in the country.
Japan Times
WORLD / Science & Health / ANALYSIS
Sep 30, 2022
Eisai drug's trial success raises hope for Alzheimer's prevention
Scientists have already begun to debate whether the benefit of the drug is robust enough, but to many researchers, the findings suggest that preventing decline altogether is possible.
Japan Times
ASIA PACIFIC / Science & Health
Sep 30, 2022
A Chinese mRNA COVID vaccine gets its first approval — in Indonesia
Indonesia's food and drugs agency approved the use of Walvax Biotechnology's mRNA vaccine, which has been in development for more than two years.
Japan Times
JAPAN / Science & Health
Sep 28, 2022
Shionogi says COVID-19 pill trial shows reduction in symptoms
The drug met the trial's goal of reducing five key symptoms of the omicron variant within 72 hours of onset, the company said.
Japan Times
JAPAN / Science & Health
Sep 28, 2022
Alzheimer’s progression slowed by drug in major trial
The drug slowed cognitive decline in people with early Alzheimer's by 27% over 18 months when compared with a placebo using a common rating scale.
Japan Times
JAPAN
Sep 12, 2022
Japan health ministry backs Pfizer and Moderna omicron boosters
Pfizer's omicron booster can be administered to people age 12 and over, while Moderna's is limited to those 18 and above, the panel advised.
Japan Times
WORLD / Science & Health
Aug 17, 2022
Why a century-old vaccine offers new hope against pathogens
The B.C.G. tuberculosis vaccine may protect against COVID-19 and other infections by broadly bolstering the immune system.
Japan Times
JAPAN
Aug 10, 2022
Shionogi confirms efficacy of oral COVID drug for omicron subvariant
The announcement came after a health ministry panel in July postponed the granting of emergency approval for the drug.
Japan Times
JAPAN / Science & Health
Aug 9, 2022
Japan to offer omicron COVID shots to people vaccinated at least twice
The vaccines have been reported to provide some increase in neutralizing antibodies against the BA.5 subtype currently prevalent across the country.
Japan Times
WORLD / Science & Health
Jul 26, 2022
Siga and peers rise on optimism over therapies to treat monkeypox
It has been a bumpy few months for shares of firms tied to the outbreak, as investors have piled in only to rush out on uncertainty about what medicine could be needed.
Japan Times
BUSINESS / Companies
Jul 6, 2022
Eisai says Alzheimer’s drug will get priority review in U.S.
Under the accelerated approval pathway, drugs can be approved based on their ability to remove amyloid, a hallmark of the disease, from the brain.
Japan Times
WORLD / Science & Health
Apr 27, 2022
With supply more abundant, U.S. pharmacies struggle to use up COVID pills
The rollout of the COVID-19 treatment Paxlovid has been far more complicated and less efficient than expected, leaving hundreds of thousands of courses unused.
Japan Times
BUSINESS / Companies
Apr 22, 2022
U.S. in talks with Japan's Shionogi to buy new COVID-19 pill
Shionogi's treatment is in late-stage clinical trials and hasn't yet been authorized, but in earlier studies, it reduced viral loads in patients within the first few days of use.
Japan Times
JAPAN
Apr 13, 2022
Shionogi to recommend pregnant women not use oral COVID drug
Shionogi has filed for conditional early approval to skip the final stage of clinical trials once a certain level of efficacy and safety has been confirmed.

Longform

Things may look perfect to the outside world, but today's mom is fine with some imperfection at home.
How 'Reiwa moms' are reshaping motherhood in Japan